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Objective: Abdominal aortic aneurysm (AAA) progression and disease resistance are related to mural cellularity;
adventitial macrophages and neocapillaries predominate in larger, advanced aneurysms, whereas smaller AAAs have fewer
macrophages and retain more medial smooth muscle cells (SMCs). Expression analysis of mRNA derived from the entire
aorta may mask the role that specific cell types play in modulating disease progression. We used laser capture
microdissection (LCM) to isolate SMC and macrophage-predominant mural cell populations for gene expression analysis
in variable-flow AAA.
Methods: Rat AAAs were created via porcine pancreatic elastase (PPE) infusion. Aortic flow was increased via femoral
arteriovenous fistula creation (HF-AAA) or reduced via unilateral iliac ligation (LF-AAA) in selected cohorts. SMC and
macrophage-predominant cell populations were isolated via LCM and analyzed for expression of pro-inflammatory
transcription factors and chemokines, cytokines, and proteolytic enzymes via real-time polymerase chain reaction.
Results: Aortic PPE infusion precipitated endothelial cell (EC) denudation, SMC apoptosis, and elastic lamellar
degeneration. Increased aortic flow (HF > NF > LF) stimulated restorative EC and SMC proliferation (45.8  6.6 >
30.5 2.1> 21 3.6 and 212.2 9.8> 136.5 8.9> 110 13.5, respectively, for both cell types; P< .05) at 5 days
after PPE infusion, while simultaneously reducing medial SMC apoptosis and transmural macrophage infiltration.
Expression of nuclear factor kappa B (NF-b), granulocyte macrophage-colony stimulating factor (GM-CSF), macro-
phage migration inhibitory (MIF), heparin-binding EGF-like factor (HB-EGF) and inducible nitric oxide synthase
(iNOS) varied between cell types and flow conditions at all time points examined. Gelatinolytic protease expression varied
by cell type in response to flow loading (eg, increased in SMCs, decreased in macrophages), consistent with observed
patterns of elastolysis and SMC proliferation reported in prior experiments.
Conclusions: Flow differentially regulates cell-specific AAA gene expression. Whole-organ analysis of AAA tissue lysates
obscures important cellular responses to inflammation and flow, and may explain previous seemingly contradictory
observations regarding proteolysis and cell proliferation. Cell-type specific expression and functional analyses may
substantially clarify the pathophysiology of AAA disease. ( J Vasc Surg 2005;41:844-52.)
Clinical Relevance:Understanding aneurysmal aortic degeneration at the most fundamental level is a critical precursor to
the development of next-generation therapies such as drug-eluting endografts and/or medical therapies to limit
expansion of preclinical AAA in high-risk or elderly patients. Although animal modeling is necessary to gain insight into
the early initiating events of AAA disease, the methods used in such analyses have critical bearing on the conclusions
drawn regarding pathogenesis and potential therapeutic derivations. By analyzing cell-type-specific gene expression
rather than whole-organ tissue lysates, the precise roles of important mediators such as metalloproteinases can be placed
in the appropriate context. Further refinement of these techniques may allow cell-specific therapies to be applied at
defined time points in disease progression with improved patient outcome and reduced procedural morbidity.From the aDivision of Vascular Surgery, Stanford University, and the
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844Aneurysmal degeneration is a common and frequently
fatal disease of the abdominal aorta. The signature patho-
physiologic events of abdominal aortic aneurysm (AAA)
disease, including mural inflammatory cell infiltration,
smooth muscle cell (SMC) loss, and elastolysis, begin years
or decades before rupture or elective repair.1 To gain
insight into the initiation and propagation of early disease,
biologically relevant rodent models have been created that
incorporate the signature pathologic and humoral events
associated with human disease.2
Longitudinal studies of experimental cohorts reveal
dramatic variations in the number and type of somatic and
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development. Cellular composition and density is further
influenced by luminal hemodynamic conditions.3 Capillary
density; macrophage location4; and vascular progenitor cell
migration, proliferation, and differentiation5 fluctuate
throughout the course of early aneurysm development.
The importance of cellular characterization lies in the spe-
cific roles that distinct cell types play in aneurysm progres-
sion. For example, macrophage but not vascular SMC
matrix metalloproteinase 9 (MMP-9) expression and activ-
ity is critical for aneurysm progression,6 whereas reduced
SMC MMP-9 activity severely restricts proliferation and
medial regeneration after injury.7
The development of effective biologic strategies for
AAA suppression8,9 ultimately depends on understanding
and manipulating the cell-specific expression of relevant
humoral mediators, enzymes, and structural proteins. To
date, however, only expression analysis from whole-organ
lysates has been performed. Averaging expression from all
infiltrative and resident cells risks misinterpreting or miss-
ing altogether the salient signaling events present during
aneurysm progression. In this study we used laser capture
microdissection (LCM) to isolate medial and adventitial
cell populations to investigate how hemodynamic condi-
tions modify time- and flow-dependent cell-type-specific
gene expression in experimental aneurysms.
MATERIALS AND METHODS
Experimental design and surgical preparation. All
experimental procedures were approved by the Institu-
tional Animal Care and Use Committee of the Veterans
Affairs Palo Alto Health Care System and were performed
in compliance with Stanford University Administrative
Panel on Laboratory Animal Care Guidelines (updated
October 1998). AAA were created in male Sprague Dawley
rats (300 to 400 g) via aortic porcine pancreatic elastase
(PPE) infusion as previously described.3,10 Briefly, the in-
frarenal aorta (approximately 15 to 18 mm in length) was
isolated, mobilized, and controlled via laparotomy. A poly-
ethylene catheter (PE-10) was advanced into the isolated
aortic segment from the right femoral artery. One milliliter
of normal saline containing 7-unit type-1 PPE (E-1250;
Sigma, St. Louis, MO) was infused via syringe pump over a
1-hour period at constant physiologic pressure.
AAA flow was modified immediately after PPE infusion
either by left common iliac artery ligation (LF-AAA) or
creation of a 2-mm left femoral arteriovenous fistula (AVF,
HF-AAA). An additional AAA cohort underwent no addi-
tional flow modifications (NF-AAA). Unilateral iliac liga-
tion reduces aortic flow 40% to 50% in this model, whereas
femoral AVF creation increases flow 250% to 300%.3,4 AAA
rats were killed at 1, 5, and 7 days after PPE infusion (n 
30 per each time point) via intentional anesthetic overdose.
Rats undergoing infusion with saline alone without flow
modification were used for positive controls, and rats with-
out any surgical intervention were used as negative controls
(n  8 in both groups). Rats designated for histologic and
ultrastructural analysis were pressure-perfused fixed with4% paraformaldehyde and 3% glutaraldehyde, respectively.
Aortic samples harvested for molecular analysis were snap
frozen in liquid nitrogen and stored at 80°C for later
analysis.
Laser capture microdissection, RNA isolation, re-
verse transcription, and real-time polymerase chain re-
action (PCR). AAA segments were embedded in OCT
(optimal cutting temperature) and frozen sections (8-m)
prepared using RNase-free technique. After staining and
dehydration according to the manufacturer’s protocol
(Arcturus Engineering Inc, Mountain View, CA; www.
arctur.com), areas of the aortic wall primarily consisting of
SMCs (media) or macrophages (adventitia) were separated
using the LCM1611 system (Arcturus) (Fig 1) with a laser
power setting of 40 mW, 7.5-m spot size, and a pulse
duration from 1 to 2 ms. Cells were selectively captured for
further analysis using CapSure LCM caps (Arcturus). Total
RNA was isolated from LCM samples separately using the
PicoPure RNA isolation kit (Arcturus, catalog no.
KIT0202) according to the manufacturer’s protocol. Total
RNA was amplified using the RiboAmpRNA amplification
kit (Arcturus, catalog no. KIT0201) to obtain amplified
RNA (aRNA), and cDNA derived from aRNA via reverse
transcription. The success of reverse transcription in creat-
ing cDNA was confirmed by amplification of -actin via
PCR (Fig 1). Real-time PCR was performed from cDNA
samples for the genes of interest (derived from prior exper-
Fig 1. Representative experimental aneurysm samples. A, Hema-
toxylin and eosin–stained AAA tissue before laser capture micro-
dissection; B, AAA after laser capture microdissection; C, immu-
nohistochemical staining for smooth muscle cells (SM- actin);D,
immunohistochemical staining for macrophages (ED-1) (original
magnification: A and B, 40; C and D, 200); E, -actin PCR
product bands (101 base pair) were detected in 2% agarose gel after
25 cycles of PCR from aRNA showing all samples containing
constant aRNA. C, control; M, mark.iments described in references 3-5, 8, and 10; Table) using
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Biosystems, Foster City, CA).8
BrdU incorporation. Selected rats in all cohorts at all
time points received intraperitoneal BrdU (50 mg/kg) in
physiologic saline solution (5 mg/mL) 1 hour before ter-
mination to determine the fraction of aortic cells in DNA
synthesis (S) phase via BrdU incorporation.
Endothelial cell (EC) and SMC density, prolifera-
tion indices. Hematoxylin and eosin–stained aortic sections
were used to calculate EC and SMC density within specific
cohorts as previously described.3,8 Additional sections were
processed for immunohistochemical staining using anti-BrdU
mouse monoclonal antibody (Becton Dickinson, Franklin
Lakes, NJ).8 EC and SMC proliferation indices were deter-
mined from counting cells from the luminal circumference
(EC) and entire cross-sectional aortic wall (SMC). 3
SMC apoptosis index. Terminal deoxynucleotidyl
transferase (TdT)-mediated dUTP nick-end labeled
(TUNEL) staining was used to detect DNA fragmentation
characteristic of apoptotic cells using an in-situ apoptosis
detection kit (ApopTag Plus Preoxidase, Intergen, New
York) following the manufacturer’s protocol. To confirm
the identify of apoptotic SMCs, sections were costained
with mouse antihuman smooth muscle- (SM-) actin
monoclonal antibody (Sigma, St. Louis, Mo) followed by
incubation with biotinylated second antibody using the
Avidid Biotinylated enzyme complex method according to
the manufacturer’s protocol. An SMC apoptosis index was
created from the fraction of SMCs identified on cross-
sectional analysis (two sections per rat) as positive double-
stained cells. All sections were counted twice and averaged
for a final value.
Macrophage infiltration index. Tissue sections were
processed for immunohistochemical staining with mouse
antirat Ectodysplasin-1 monoclonal antibody (Serotec Inc,
Raleigh, NC), followed by biotinylated second antibody
according to the manufacturer’s protocol as previously
described.4 Analysis of adventitial macrophage infiltration
was created from counting cells from the entire cross-
sectional area. Specimens were counted twice and averaged
for a final value.
Substrate gel zymography. Snap frozen AAA samples
(n 3/flow group/time point) were pooled for substrate gel
zymography. AAA were pulverized in liquid nitrogen and
Primers used in RT-PCR
Gene Bank no. Forward primer
NF-kB AF187319 5’-GGCTGGGCCAAGATCTCTAAC
GM-CSF U00620 5’-TCAAAGAAGCTCTGAGCCTCC
MIF NM031051 5’-GAACCGCAACTACAGCAAGCT
HB-EGF L05489 5’-CTGAGATGGCGGTTCCTTACA
iNOS NM012611 5’-CGATGCCCGGAGCTGTAG-3’
MMP-2 NM031054 5’-TGC TGG AGA ACC TGA AGTG
MMP-9 U36476 5’-GGCCTATTTCTGCCATGACAAA
-actin L40991 5’-CAGCAGAGCCTGCCGTAATC-3extracted in ice-cold 50-mM Tris-HCl buffer, pH 7.5, con-taining 10 mM CaCl2, 2.0 M guanidine hydrochloride, and
2.5%TritonX-100. Zymographywas performed as previously
described.3 Densitometric analysis of lytic bands for MMP-2
and MMP-9 were performed by public domain software Na-
tional Institutes of Health Image version 1.61.
Ultrastructural examination. Specimens for scan-
ning (SEM) or transmission electron microscopy (TEM)
were prepared as previously described5 and imaged with
either a JSM-5200 (JEOL Co, Tokyo, Japan) or a
LEM2000 (Topson Co, Tokyo, Japan) microscope, re-
spectively.
Statistical analysis. All data were expressed as mean
SD. Statistical analysis was performed using two-way anal-
ysis of variance (ANOVA) with the Bonferroni/Dunn post
hoc test for nonnormally distributed populations. Differ-
ences were considered statistically significant at P  .05.
RESULTS
Aortic PPE infusion precipitated EC denudation, SMC
apoptosis (Fig 2), and elastic lamellar degeneration in all
experimental groups. Restorative endothelial and SMC
proliferation began within 1 day and peaked at 5 days after
infusion; proliferation indices and cellular density were
directly related to luminal flow conditions (HF	NF	LF;
Fig 3,A, B, D, E). Flow loading also reduced SMC apopto-
sis (Fig 3, C) and transmural macrophage infiltration (Fig
3, F) in a stepwise fashion at 5 days. As a result of some or
all of these cellular responses, AAA diameter was inversely
related to luminal flow (LF 	 NF 	 HF) consistent with
previous observations.3-5,10
The potential consequences of cell-type-specific vs
whole-organ gene expression analysis are highlighted in
Figs 4 and 5. Expression of the pro-inflammatory transcrip-
tion factor nuclear factor-kappa B (NF-
b) was seen pre-
dominantly in LF-AAA macrophage-rich regions, consis-
tent with previous observations regarding the influence of
reduced flow on AAA progression and inflammation.4,10-12
NF-
b expression was limited almost entirely to infiltrative
macrophages rather than SMCs (Fig 4a). Granulocyte mac-
rophage–colony stimulating factor (GM-CSF) expression
from whole-organ lysates has shown little consistent rela-
tionship to AAA flow in this (Fig 4, B) or previous4 exper-
iments. GM-CSF is a potent arteriogenic cytokine that also
regulates macrophage proliferation and differentiation and
Reverse primer
Product size
(base pairs)
5’-TGATGCCTGAAGCAAATGTTG-3’ 101
’ 5’-CGGCCTCTGGATGGAGAAC-3’ 101
5’-TGGCTGCGTTCATGTCGTAA-3’ 101
5’-AGGCCCAGTCAGGGTAGCA-3’ 101
5’-CAGTAATGGCCGACCTGATGT-3’ 101
5’-AGA TTG ATG CCG TGT ACG AG-3’ 275
-3’ 5’-CTGCACCGCTGAAGCAAAAG-3’ 141
5’-CGATGAGGTTCCGCGAGAT-3’ 101-3’
TA-3
-3’
-3’
T-3’
TACtherefore may be expected to play potentially divergent
ytopl
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vs mesenchymal cell proliferation and retention).13,14
Within the distinct cell populations isolated by LCM, how-
ever, flow had consistent and opposing consequences on
gene expression; reduced flow increased GM-CSF expres-
sion in macrophage-rich areas, whereas HF increased ex-
pression in SMC-rich areas. Macrophage migration inhibi-
tory factor (MIF) message was also increased most
significantly in LF-AAA macrophage-rich areas, with step-
wise flow-related reductions present in both macrophage-
and SMC-rich regions (Fig 4, C).
We have previously shown that high flow induces me-
dial SMC proliferation and retention,3 and that medial
SMC density is inversely related to experimental aneurysm
progression.15 Heparin-binding endothelial growth fac-
tor–like growth factor (HB-EGF), a potent mitogen for
vascular SMCs induced during oxidative and environmen-
tal stress,16 was strongly expressed in both macrophage-
and SMC-rich regions in stepwise response to increased
flow. Of interest, expression peaked at day 1 in macro-
phages vs day 5 in HF-AAA SMC-rich areas (Fig 4, D).
Inducible nitric oxide synthase (iNOS), previously impli-
cated in the pathogenesis of experimental17 and human
AAA disease,18 but paradoxically also proposed to play a
vasoprotective role in age-related diseases of the arterial
Fig 2. Ultrastructural analysis of experimental AAA. En
day 1 after PPE infusion (A and B). Apoptotic medial s
nuclear chromatin condensation (arrows) and vacuolar cmedia when produced by SMCs,19 increased expression ina stepwise fashion in response to flow in SMC-rich areas.
No flow differential was noted in macrophage-rich areas
(Fig 4, E).
Proteolytic enzyme expression also varied in distinct
ways between cell types and flow conditions. Analysis of
whole-organ AAA MMP-2 gene expression showed in-
creased expression in LF-AAA vs NF- or HF-AAA at days 5
and 7. No significant effect of flow conditions (high or low)
on AAA MMP-9 expression was noted (Fig 5, A, B).
Cell-type-specific flow-related changes were noted, how-
ever, from LCM specimens: first, MMP-2 expression was
increased in LF- vs HF- or NF-AAA at days 5 and 7 in
macrophage-rich areas but reduced in LF- vs HF- or NF-
AAA in SMC-rich areas; and second, MMP-9 expression
was reduced in macrophage-specific areas at days 1 and 5 in
HF-AAA and increased in SMC-rich areas at days 5 and 7 in
HF-AAA. MMP-14, TIMP-1, and TIMP-2 genes were
expressed in parallel with MMP-2 and 9 (data not shown).
The gelatinolytic consequences of MMP-2 and -9 expres-
sion are shown in Fig 6. Increased activity of the pro- and
active forms of both proteinases was noted in NF- and
HF-AAA at all time points.
DISCUSSION
Evolving AAAs undergo significant fluctuations in cel-
elial cell denudation and luminal microthrombi present
h muscle cells (C and D) were conspicuous for distinct
asm (arrowheads). SM, smooth muscle cell.doth
mootlular composition and density. By using LCM in these
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pression of important molecular mediators of disease pro-
gression and resistance. Prior analyses of human and exper-
imental AAA tissue have relied on mRNA extraction from
whole-organ lysates largely without regard to cell type or
cell density. Our results show that whole-organ analyses
may obscure important regulatory signaling activities from
constitutive aortic and infiltrative inflammatory cells.
In LCM, laser energy activates a special transfer film
that bonds to cells identified and targeted by light micros-
copy within the tissue section. The transfer film is then
Fig 3. Flow-dependant cell proliferation and SMC
functions of time and flow conditions (LF-, NF-, or H
lumen (CSL); B, BrdU-labeled SMCs/cross-sectiona
ECs/CSL; E, Number of SMCs/high-power field; F
LF-AAA; †P  .05 vs LF-AAA.lifted off the thin tissue section, leaving unwanted cellsbehind. This enables isolation of relatively pure cell popu-
lations for gene expression analysis. mRNA harvested from
as few as 100 cells using this method may be amplified via
PCR to achieve sufficient quantities for differential analy-
sis.15 Although this method limits absolute quantification,
it does enable comparison of expression ratios of genes of
interest under variable-flow conditions between SMC- and
macrophage-predominant areas. These targeted tissue
specimens also contain some stray nontargeted cells, in-
cluding neutrophils, capillary endothelial cells, fibroblasts,
nontargeted macrophages, and SMCs; therefore, not all
tosis. All panels represent specific cellular indices as
A). A, BrdU-labeled endothelial cells/cross-sectional
a (CSA); C, Apoptotic SMCs/CSA; D, Number of
mber of macrophages/CSA. *P  .05 vs NF- andapop
F-AA
l are
, Numessage was derived exclusively from principal cells of
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specimens. Data reported as expression ratios to control aortic tissue. *P  .05 vs NF- and LF-AAA; †P  .05 vs
LF-AAA.
s NF-
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ever, that targeted cells constituted more than 90% of all
cellular elements in enriched areas and as such represented
a far more focused analysis of cell-specific gene expression
than that previously available. LCM also minimizes inclu-
Fig 5. Comparison of MMP-2 and MMP-9 gene expr
reported as the ratio to control aortic tissue. *P  .05 v
Fig 6. MMP-2 and -9 gelatinolytic activity in experimental AAA.
C, normal control aorta; pro-form MMPs, band consistent with
molecular weight of precursor form of MMP before activation;
active-form MMPs, band consistent with molecular weight of
MMP after activation. Both pro-form and active-form MMP
isozymes have gelatinolytic activity. *P .01 vs pro-formMMP-2;
†P  .01 vs pro-form MMP-9.sion of apoptotic and necrotic cells and hypocellular ele-ments (collagen, elastin, basement membrane, etc) that
dilute or potentially contaminate mRNA extraction and
purification.
We have previously shown that flow conditions modu-
late AAA diameter and cell composition, density, and loca-
tion in rats and mice. In experimental AAA, increased flow
and wall shear stress promote luminal EC proliferation,
medial SMC retention, and diminished macrophage infil-
tration. Reduced flow limits restorative cellular prolifera-
tion and retention and promotes transmural macrophage
infiltration.3,4 Correlation of the consequences of evolving
AAA cellularity and disease progression has been compli-
cated by contradictory information regarding important
mediators such as MMP-9. MMP-9 clearly plays a critical
and rate-limiting role in progressive aortic proteolysis and
aneurysm enlargement.6,16 However, increased MMP-9
expression and activity are present in HF- as compared with
NF- or LF-AAA, despite the fact that HF-AAA has a smaller
luminal diameter.3,5
The current results highlight the importance of identi-
fying cell-specific expression of critical mediators such as
MMP-2 and -9 and the likelihood that they may have
divergent and/or off-setting influences based on location,
timing, and magnitude of expression. Both MMP-2 and -9
are expressed by endothelial cells and SMCs as well as
infiltrative macrophages in experimental AAA. In this ex-
periment, high-flow conditions increased MMP-2 and -9
expression in SMC-rich areas, and low-flow conditions
increased MMP-2 and -9 expression in macrophage-rich
areas. In the case of MMP-9, whereas macrophage-specific
n in total AAA tissue and cell-specific areas. Data were
and LF-AAA; †P  .05 vs LF-AAA.essioexpression is required for AAA progression, targeted dele-
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migration and cell proliferation.7 Under these circum-
stances, non–cell specific MMP-9 inhibition strategies may
ultimately yield confounding and deleterious results if com-
pensatory and restorative SMC proliferation is similarly
inhibited. Similar observations may hold true for inhibition
strategies aimed at cytokines such as GM-CSF or iNOS
that, in addition to their well-characterized pro-inflamma-
tory influences, may also play critical roles in mesenchymal
cell proliferation and arteriogenesis and are highly ex-
pressed in the relatively robust medial layer of smaller
HF-AAA.
Analysis of cell-specific gene expression also adds depth
and context to previously recognizedmorphologic patterns
characteristic of variable-flow AAA. For example, adventi-
tial macrophages are more prevalent in LF-AAA.4 Al-
though not apparent from whole-organ tissue lysates, flow
clearly influences MIF expression; cell-type-specific analysis
clearly shows time- and flow-dependant expression in both
macrophages and SMCs consistent with observed macro-
phage tissue densities. In the case of NF-
b, it is apparent
that essentially all flow-related expression is derived from
macrophages alone. Increased expression of endothelial-
derived growth factors such as HB-EGF supports the mor-
phologic recognition of increased SMC proliferation and
density in HF-AAA, a relationship also not apparent from
analysis of transmural whole-organ gene expression.
In summary, isolation of relatively pure cell populations
within experimental AAAs provides novel and important
insights into disease progression and hemodynamic modu-
lations. Development of new and innovative biologic treat-
ment strategies for AAA disease will require further in-
depth analysis of time- and cell-dependant expression of
mediators of interest.
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Dr Larry Kraiss (Salt Lake City, Utah). I am going to focus
my discussion primarily on what Dr Sho told us about MMP
expression.
We know from gene knock-out studies in experimental aneu-
rysms that matrix metalloproteinase expression is absolutely critical
for aneurysm development, and if these genes are knocked out,
aneurysms don’t occur. But these same molecules or proteases are
very important for healthy blood vessels to remodel and to adapt to
structural changes to their environment. So by whole organ anal-entire aorta and measure MMP expression in the entire aorta, you
get some confusing results. For instance, in their study animals that
were destined to develop larger aneurysms had the same amount of
MMP expression as animals that were destined to have smaller
aneurysms. If they had stopped there, the role of MMP expression
in aneurysm development would have remained clouded in uncer-
tainty. I think they are to be congratulated for probing deeper and
using laser capture microdissection to show us that there is a
difference in where these genes are expressed in animals that go on
to develop large aneurysms versus small aneurysms. The larger
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rich areas, whereas smaller aneurysms had higher MMP expression
in the smooth muscle cell-rich areas. The clear implication is that
aneurysms result from unregulated MMP expression by macro-
phages and inflammatory cells as opposed to smooth muscle cells.
This result would have been missed by traditional whole organ
analysis. I have two questions for the authors.
First, I am concerned that they overstate their results by
claiming they have measured cell-specific gene expression. Even a
small minority of contaminating or different types of cells within
their relatively pure samples could have produced the same result if
the minority cells had very robust expression of a gene as measured
by PCR, which is the technique that they used. I would submit to
them that before they can actually make a claim that they have
identified cell-specific gene expression in these developing aneu-
rysms, that they need to use some complementary techniques such
as in-situ hybridization.
My question is whether or not they believe that measurement
of the messenger RNA for the MMPs actually correlates with final
MMP proteolytic activity. These molecules are subject to a whole
host and range of regulatory check points along the way to expres-
sion of the active protease including multiple post-transcriptional
check points, including inhibitors of the active protease. Do the
authors know whether or not actual MMP activity is different in
these regional areas in the same way that they have measured
differences in mRNA expression?
Finally, I think a PubMed search reveals that Dr Sho’s paper
from Dr Dalman’s group is the first to apply laser capture micro-
dissection to this problem and I think it really represents an
advance and allows more sophisticated analysis into this problem.
This tool is going to keep their group busy for quite some time in
the future.
Dr Eiketsu Sho. MMPs are important for vascular remodel-
ing and aneurysm formation. In our studies we also found by flow
regulation we can modulate proteinase expression both in smooth
muscle cells and macrophages. We currently believe that MMP-9
derived from smooth muscle cells may facilitate SMC migration
and proliferation, stabilizing AAA, while MMP-9 expression from
macrophages may accelerate aneurysm enlargement.
Regarding confirmatory protein analysis, we were unable to
maintain zymographic activity during the capture process due to
very high temperatures. We are continuing to explore alternativemethods of performing these assays. In-situ hybridization will also
be helpful in confirming the cell-specific expression data.
Dr Ronald L. Dalman (Palo Alto, Calif). We are doing some
in-situ hybridization that we have not completed. It will most likely
be necessary for getting the manuscript published. The site-specific
zymography is technically very challenging and we have not been
able to accomplish that. Your comments are right on the mark.
There is going to be no such thing as a totally cell-specific gene
analysis. We can only look at cellular-rich areas, so there are some
semantic issues involved in how we describe the process. Clearly
this is a much better method of getting at cell-specific gene
expression than simply using whole organ tissue preparation, so
this is kind of a work in progress in that regard.
Dr Glenn Hunter (Galveston, Tex). I have a couple of
questions related to the laser capture. How many sections did you
actually evaluate, because when you do laser capture, how many
sections per aneurysm did you actually section, because one of the
problems with laser capture is sample bias.
The other question, to get enoughRNAor protein to do some
of the things you have to do, were the results pooled that you were
presenting or howmany cells did you get out of each specimen that
you captured?
Dr Sho. For the laser capture sections, I selected three sec-
tions from each sample and every, I think, every 50 microns we
selected one section. For the smooth muscle cells I collected more
than 500 cells and for the macrophages more like 1000 cells.
During amplification maybe sometimes we can lose the total
length of the mRNA sequence, so we tried to compensate for this
and tried to keep it as long as a total RNA sequence so we would
not lose the signal.
Dr Hunter. I congratulate you. It is very interesting work.
Dr Dalman. If I could just make a final comment. Members
may remember that last year we presented a paper on doxycycline
infusion system to potentially limit aortic aneurysm progression as
an adjunct to aortic endografting. This report dovetails along with
that work, attempting to answer the question of what mediators
are most effective at what time point in the progression of abdom-
inal aortic aneurysm disease. To really answer that question we
realized that we needed a better understanding of what is happen-
ing at the cellular level. As Larry alluded to in his summary of our
project, that was the primary focus of this paper. We are continuing
to work in this area.
